P/E ratio for Aethlon Medical (AEMD)

P/E ratio history for Aethlon Medical from 2001 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Inovio Pharmaceuticals INO	-8.49	9,394.37%	🇺🇸 USA
Coherent COHR	-37.4	41,662.66%	🇺🇸 USA
Bruker BRKR	27.9	-31,264.83%	🇺🇸 USA
Pacific Biosciences PACB	-1.93	2,056.76%	🇺🇸 USA
Accelerate Diagnostics AXDX	-0.2503	179.85%	🇺🇸 USA
PerkinElmer PKI	15.0	-16,832.61%	🇺🇸 USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.